We offer our fully-fledged FDF portfolio to partners around the globe, blending our strong heritage in mental health and the central nervous system with a wide offering in ten additional therapeutic areas. In particular, we devote our efforts to the development of value-added products with highly beneficial effects on the patients’ treatment. And we do it with an innate passion and perseverance to move health forward for our customers and patients across the globe.
Our FDF portfolio comprises one of the broadest CNS offerings along with a complete range of most therapeutic areas. We offer more than 85 FDFs for 40 indications in more than 100 presentations and strengths. We also provide a wide range of nutritional supplements and vitamins.
Offering value-added products is at our core. Our FDF portfolio includes a number of innovative presentations which improve patients’ treatments through easier dosing and better adherence. We also offer several renowned brands such as Buccolam® and Preventan® which are sound market-leaders in their segments.
As the international business unit of Neuraxpharm, we are continuously seeking new partners on a global level. We are now present in more than 35 countries and will be entering more than 10 new markets by 2022.
We out-license our products to 3rd parties on a worldwide level. Our portfolio covers CNS and most therapeutic areas, with more than 85 EU/US CTD dossiers.
If you are interested in distributing our products in your country, we also offer distribution agreements, both exclusive and non-exclusive.
We are open to discuss any other partnership model you are looking for. Just reach out!
Forty years in the pharmaceutical sector have enabled us to create decades-long relationships with our partners, reflecting our flexibility and strong customer orientation. We currently work with more than 100 partners on a European and worldwide level.
We commit ourselves to improving patients’ health and lives. That’s why we offer value-added FDFs and market-leading brands that enhance their treatments. Our one-of-a-kind portfolio comprises CNS products along with a complete offering in most therapeutic areas.
Flexibility and customer orientation throughout the whole value chain are embedded in our culture. We deliver the API or FDF you are looking for, ensure highest quality through our own manufacturing facilities, offer a broad scope of presentations and always deliver on time.
Our European heritage makes us experts in highly regulated markets and thus a solid partner to operate across the world.
Our regulatory teams are behind our commercial activities to support the partners’ local registration procedures in the licensed territories.
Please leave us a message and we promise to come back to you very quickly!
Seasonal allergic rhinitis
Asthma, allergic rhinitis
Acute coronary syndrome
Risk of heart disease & stroke
Irritbale bowel síndrome
Primary biliary cirrhosis
Agitation and restlessness
Parkinson disease & restless legs
Psychomotor agitation & sleep disorder
Schizophrenia & bipolar disorders
Sleep disorders & psychomotor restlessness
Tardive dyskinesia, Huntington